Skip to main content

CorWave

CorWave Wins 2021 Healthtech Award

https://www.corwave.com/wp-content/uploads/2021/10/20211019-PR_Healthtech-Awards-v5fin_website.pdf

CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting

https://www.corwave.com/wp-content/uploads/2021/06/20210614-PR_In-Vivo_90_Days.pdf

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

https://www.corwave.com/wp-content/uploads/2021/04/20210427_CorWave_PR_ISHLT.pdf

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

https://www.corwave.com/wp-content/uploads/2021/01/PR_Series-C_EN_.pdf

CorWave Secures a €500,000 Grant From the Paris Region for Its Industrial Facilities

https://www.corwave.com/wp-content/uploads/2020/11/20201119_CorWave_PR_Relance_Industrie.pdf

CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program

https://www.corwave.com/wp-content/uploads/2020/07/EIC-Acc-Grant.pdf

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting

https://www.corwave.com/wp-content/uploads/2020/06/20200610_CorWave_PR_EN_2-milestones_ASAIO-Top-Abstract.pdf

M&L GROUP

We are a family investment firm that cultivates pioneering ventures into successful enterprises with passion, energy and integrity.

Hospitality
Healthcare
Shipping
Alternatives
Media room
About
Contact

Copyright © 2025 M&L Group. All Rights Reserved. | Legal.

Branding and website design by Stepworks